Head and Neck Cancer Clinical Trial
Official title:
An Exploratory Study on Optical Assessment of Oral Mucositis
Objectives:
1. To assess the tolerability of performing optical coherence tomography and/or optical
spectroscopy in patients with acute oral mucositis.
2. To determine the feasibility of obtaining optical coherence tomography images and/or
fluorescence excitation emission matrices from normal and affected sites in patients
with acute oral mucositis.
3. To compare optical data obtained with optical coherence tomography and/or spectroscopy
with the clinical appearance and scoring of oral mucositis lesions.
Optical coherence tomography (OCT) works similarly to ultrasound but uses infrared light
waves rather than sound waves to create high-resolution pictures. This tool has been
approved by the Food & Drug Administration (FDA), is used routinely for standard diagnosis
of eye conditions, and is now being used to look inside your mouth for tissue changes.
For the OCT procedure, a small probe, about the size of a pencil eraser, will be gently
placed against the lining of your mouth and light will be shone through the probe to create
pictures of the tissue. The probe will be placed on 1-2 abnormal-looking areas and 1
normal-looking area inside the mouth. If there are no abnormal-looking areas, researchers
will place the probe and make pictures of an area on the inside of the cheek and side of the
tongue, since these are the areas most often affected by the chemotherapy and radiation
therapies.
In fluorescence spectroscopy (FS), a small beam of light, shines through a small probe onto
the lining of the mouth. A small amount of light will be emitted from the tissue in the form
of fluorescence, similar to "glow in the dark" toys . This light is not seen by the eye, but
it is detected by the probe and recorded by a computer.
For the FS procedure, a small probe, about the size of a pencil eraser, will be gently
placed against the lining of your mouth and light will be shone through the probe. The probe
will then collect the fluorescence light signals and they will be recorded on a computer.
The probe will be placed on 1-2 abnormal-looking areas and 1 normal-looking area inside the
mouth. If there are no abnormal-looking areas, researchers will place the probe and make
pictures of an area on the inside of the cheek and side of the tongue, since these are the
areas most often affected by the chemotherapy and radiation therapies.
If you agree to take part in this study, your mouth will be examined before your treatment
begins, and then once a week after that. Every week, you will also be asked how much pain
you are having on a scale of 1-10.
Photographs will be taken of the inside of the mouth with a standard camera. You will not be
identified in these photographs.
You will be asked to return once a week until you finish all radiation treatments to have
all the exams repeated. Most radiation treatments last about 6-8 weeks.
This is an investigational study. About 18 patients will take part in this study. All will
be enrolled at M. D. Anderson.
;
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05808920 -
The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
|
||
Completed |
NCT02526017 -
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers
|
Phase 1 | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT03997643 -
Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT04700475 -
Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients.
|
N/A | |
Withdrawn |
NCT04058145 -
AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
|
Phase 2 | |
Completed |
NCT02572869 -
Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps
|
||
Active, not recruiting |
NCT04474470 -
A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer
|
Phase 1/Phase 2 | |
Withdrawn |
NCT05073809 -
Photoacoustic Imaging of Head and Neck Tumours
|
||
Active, not recruiting |
NCT04383210 -
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
|
Phase 2 | |
Active, not recruiting |
NCT03651570 -
Randomized Controlled Trial of a E-intervention to Help Patients Newly Diagnosed With Cancer Cope Better: Pilot Study
|
N/A | |
Recruiting |
NCT04930432 -
Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06016699 -
Immunological Function After Radiation With Either Proton or Photon Therapy
|
||
Terminated |
NCT03843554 -
Commensal Oral Microbiota in Head and Neck Cancer
|
N/A | |
Recruiting |
NCT05915572 -
Mulligan Technique on Shoulder Dysfunction
|
N/A | |
Completed |
NCT05897983 -
Tens and Rocabado Exercises on TMJ Dysfunction
|
N/A | |
Not yet recruiting |
NCT06289049 -
Heavy Strength Training in Head and Neck Cancer Survivors
|
Phase 2 | |
Withdrawn |
NCT05263648 -
Virtual Reality Software to Reduce Stress in Cancer Patients
|
N/A | |
Withdrawn |
NCT03238638 -
A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy
|
Phase 2 |